Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_49769 | 11 | 0.23 | Mlig455_004340, Mlig455_004350 | Neo: - Age: Up-Down-Down |
ANOS1 | Mlig455_004340 {REF} {Length: 3275} {Pfam: Fibronectin type III domain [PF00041.23, score=59.5]} {Human: ENSG00000011201, ANOS1, anosmin 1, [Score=114, Expect=6e-26]} {Dmel: FBgn0039155, Kal1, Kallmann syndrome 1, [RH, Score=83.2, Expect=2e-16]} {Celegans: WBGene00002181, kal-1, KALlmann syndrome homolog, [Score=86.3, Expect=3e-17]} {Smed: dd_Smed_v6_10075_0_1, dd_Smed_v6_10075_0_1, [Score=152, Expect=2e-38]} {RNA1509_44032} {RNA1310_20852} {RNA815_15013} Mlig455_004350 {REF} {Length: 3028} {Pfam: Fibronectin type III domain [PF00041.23, score=83.9]} {Human: ENSG00000011201, ANOS1, anosmin 1, [Score=126, Expect=1e-29]} {Dmel: FBgn0039155, Kal1, Kallmann syndrome 1, [RH, Score=85.9, Expect=4e-17]} {Celegans: WBGene00002181, kal-1, KALlmann syndrome homolog, [Score=90.1, Expect=2e-18]} {Smed: dd_Smed_v6_10075_0_1, dd_Smed_v6_10075_0_1, [Score=183, Expect=3e-48]} {RNA1509_44032} {RNA1310_20852, RNA1509_44032} {RNA1509_44032, RNA815_15013} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.374 | 0.611 | 0.99975 | 1.00000 | |
RegionR2 | 0.615 | 0.611 | 0.99985 | 1.00000 | |
RegionR3 | 0.069 | 0.611 | 0.99985 | 1.00000 | |
RegionR4 | -0.753 | 0.611 | 0.99986 | 1.00000 | |
RegionR5 | -0.263 | 0.611 | 0.99996 | 1.00000 | |
RegionR6 | -0.008 | 0.611 | 0.99982 | 1.00000 | |
RegionR7 | 0.289 | 0.611 | 0.99973 | 1.00000 | |
RegionR8 | 0.426 | 0.611 | 0.99989 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 0.407 | 0.611 | 0.99976 | 1.00000 | |
RegenerationR2 | 4.414 | 0.611 | 0.07837 | 0.45173 | |
RegenerationR3 | 2.37 | 0.611 | 0.99954 | 1.00000 | |
RegenerationR4 | 0.287 | 0.611 | 0.99961 | 1.00000 | |
RegenerationR5 | 0.141 | 0.611 | 0.99968 | 1.00000 | |
RegenerationR6 | 0.144 | 0.611 | 0.99989 | 1.00000 | |
RegenerationBL | -0.024 | 0.611 | 0.99973 | 1.00000 | |
RegenerationTP | 0.008 | 0.611 | 0.99989 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_49769 | 11 | 0.23 | Mlig455_004340, Mlig455_004350 | Neo: - Age: Up-Down-Down |
ANOS1 | 2 | - | - | - | - | 1.000 | 1.000 | Mlig455_004340 {REF} {Length: 3275} {Pfam: Fibronectin type III domain [PF00041.23, score=59.5]} {Human: ENSG00000011201, ANOS1, anosmin 1, [Score=114, Expect=6e-26]} {Dmel: FBgn0039155, Kal1, Kallmann syndrome 1, [RH, Score=83.2, Expect=2e-16]} {Celegans: WBGene00002181, kal-1, KALlmann syndrome homolog, [Score=86.3, Expect=3e-17]} {Smed: dd_Smed_v6_10075_0_1, dd_Smed_v6_10075_0_1, [Score=152, Expect=2e-38]} {RNA1509_44032} {RNA1310_20852} {RNA815_15013} Mlig455_004350 {REF} {Length: 3028} {Pfam: Fibronectin type III domain [PF00041.23, score=83.9]} {Human: ENSG00000011201, ANOS1, anosmin 1, [Score=126, Expect=1e-29]} {Dmel: FBgn0039155, Kal1, Kallmann syndrome 1, [RH, Score=85.9, Expect=4e-17]} {Celegans: WBGene00002181, kal-1, KALlmann syndrome homolog, [Score=90.1, Expect=2e-18]} {Smed: dd_Smed_v6_10075_0_1, dd_Smed_v6_10075_0_1, [Score=183, Expect=3e-48]} {RNA1509_44032} {RNA1310_20852, RNA1509_44032} {RNA1509_44032, RNA815_15013} |
2. | MligTC455_20088 | 39 | 0.81 | Mlig455_017821 | Neo: - Age: Up-Down-Down |
GLIPR1 | 1.987 | - | - | - | - | 0.987 | 1.000 | Mlig455_017821 {REF} {Length: 2083} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=62.2]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [Score=89.4, Expect=2e-19]} {Mouse: ENSMUSG00000025431, Crisp1, cysteine-rich secretory protein 1, [RH, Score=84.3, Expect=5e-18]} {Dmel: FBgn0038126, CG8483, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=78.6, Expect=5e-16]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=143, Expect=7e-37]} {RNA1310_43937.1} {RNA815_38891} |
3. | MligTC455_50794 | 32 | 0.67 | Mlig455_026944, Mlig455_027032, Mlig455_027095 | Neo: - Age: - |
1.984 | - | - | - | - | 0.984 | 1.000 | Mlig455_026944 {REF} {Length: 1102} {Pfam: Lectin C-type domain [PF00059.23, score=41.7]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [RH, Score=73.2, Expect=1e-15]} {RNA1310_33496.1} {RNA815_23317} Mlig455_027032 {REF} {Length: 1107} {Pfam: Lectin C-type domain [PF00059.23, score=45.3]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [RH, Score=72.4, Expect=3e-15]} {RNA1310_33496.1} {RNA815_23317} Mlig455_027095 {REF} {Length: 1081} {Pfam: Lectin C-type domain [PF00059.23, score=43.8]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=66.6, Expect=4e-13]} {RNA1310_33496.1} {RNA815_23317} |
|
4. | MligTC455_11701 | 54 | 1.12 | Mlig455_042837, Mlig455_045855, Mlig455_045871 | Neo: - Age: - |
1.98 | - | - | - | - | 0.980 | 1.000 | Mlig455_042837 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045855 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045871 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} |
|
5. | MligTC455_55986 | 9 | 0.2 | Mlig455_047193 | Neo: - Age: - |
1.978 | - | - | - | - | 0.983 | 0.995 | Mlig455_047193 {REF} {Length: 348} {NoTransDecoderORF} | |
6. | MligTC455_17299 | 538 | 11.21 | Mlig455_036559, Mlig455_057787 | Neo: - Age: - Region-enriched R2: 5.046/0.00000 |
1.969 | - | - | - | - | 0.975 | 0.994 | Mlig455_036559 {REF} {Length: 718} {RNA1509_57277} {RNA1310_52579, RNA1509_57277} {RNA1509_57277, RNA815_26706} Mlig455_057787 {REF} {Length: 741} {RNA1509_57277} {RNA1310_52579} {RNA815_26706} |
|
7. | MligTC455_10886 | 28 | 0.58 | Mlig455_046889 | Neo: - Age: - |
1.965 | - | - | - | - | 0.972 | 0.993 | Mlig455_046889 {REF} {Length: 1896} {NoTransDecoderORF} | |
8. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
1.96 | - | - | - | - | 0.960 | 1.000 | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
9. | MligTC455_51759 | 40 | 0.83 | Mlig455_026782 | Neo: - Age: - Region-enriched R4: 4.435/0.02831 |
CNBD2 | 1.956 | - | - | - | - | 0.962 | 0.994 | Mlig455_026782 {REF} {Length: 2590} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=70.9]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=65.1, Expect=2e-10]} {Mouse: ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=62.4, Expect=1e-09]; ENSMUSG00000038085, Cnbd2, cyclic nucleotide binding domain containing 2, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0037837, CG14693, [RH, Score=53.9, Expect=3e-07]} {Celegans: WBGene00015650, pkg-2, Protein Kinase, cGMP-dependent, [Score=58.9, Expect=8e-09]} {Smed: dd_Smed_v6_17565_0_1, dd_Smed_v6_17565_0_1, [Score=171, Expect=1e-45]} {RNA1310_33768} {RNA815_47620} |
10. | MligTC455_49451 | 16 | 0.34 | Mlig455_030374 | Neo: - Age: - |
NOX5 | 1.952 | - | - | - | - | 0.952 | 1.000 | Mlig455_030374 {REF} {Length: 890} {Pfam: EF hand [PF00036.34, score=93.4]; EF-hand domain [PF13405.8, score=86.0]; EF hand [PF13202.8, score=73.1]; EF-hand domain pair [PF13499.8, score=70.3]; EF-hand domain pair [PF13833.8, score=49.3]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=29.0]; EF-hand domain [PF14658.8, score=23.2]; Caleosin related protein [PF05042.15, score=20.4]; EF-hand domain [PF17958.3, score=19.8]} {Human: ENSG00000255346, NOX5, NADPH oxidase 5, [Score=67.4, Expect=2e-13]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.5, Expect=3e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=63.2, Expect=4e-13]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=63.2, Expect=4e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=63.2, Expect=4e-13]} {Dmel: FBgn0033238, azot, ahuizotl, [Score=64.3, Expect=1e-13]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=62.4, Expect=6e-13]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=101, Expect=2e-28]} {RNA1310_74457} |
11. | MligTC455_00632 | 11 | 0.23 | Mlig455_009708 | Neo: - Age: - |
1.951 | - | - | - | - | 0.953 | 0.998 | Mlig455_009708 {REF} {Length: 1293} {Pfam: Photosystem I protein M (PsaM) [PF07465.15, score=31.8]} | |
12. | MligTC455_14307 | 7 | 0.14 | Mlig455_010232 | Neo: - Age: - |
1.95 | - | - | - | - | 0.970 | 0.980 | Mlig455_010232 {REF} {Length: 2384} {Pfam: Endonuclease-reverse transcriptase [PF14529.8, score=55.8]; Endonuclease/Exonuclease/phosphatase family [PF03372.25, score=20.8]; PHD-finger [PF00628.31, score=19.7]} {RNA1310_115972} | |
13. | MligTC455_19454 | 11 | 0.23 | Mlig455_034200 | Neo: - Age: - |
KREMEN1 | 1.95 | - | - | - | - | 0.950 | 1.000 | Mlig455_034200 {REF} {Length: 1253} {Pfam: WSC domain [PF01822.21, score=46.0]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=55.5, Expect=6e-08]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=57.8, Expect=6e-09]} {RNA1310_36702.1} {RNA815_33128} |
14. | MligTC455_28575 | 27 | 0.55 | Mlig455_028366, Mlig455_052765 | Neo: - Age: - |
1.95 | - | - | - | - | 0.954 | 0.996 | Mlig455_028366 {REF} {Length: 771} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_22744} {RNA815_55880} Mlig455_052765 {REF} {Length: 1415} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_15798} {RNA1310_22744} {RNA815_55880} |
|
15. | MligTC455_10546 | 13 | 0.27 | Mlig455_011137 | Neo: - Age: - |
1.941 | - | - | - | - | 0.946 | 0.995 | Mlig455_011137 {REF} {Length: 173} {NoTransDecoderORF} | |
16. | MligTC455_43326 | 39 | 0.8 | Mlig455_057987 | Neo: - Age: - |
1.94 | - | - | - | - | 0.956 | 0.984 | Mlig455_057987 {REF} {Length: 1058} {RNA1310_129308} | |
17. | MligTC455_50644 | 37 | 0.77 | Mlig455_008094 | Neo: - Age: - |
VSX1 | 1.939 | - | - | - | - | 0.944 | 0.995 | Mlig455_008094 {REF} {Length: 1368} {Pfam: Homeodomain [PF00046.31, score=79.6]} {Human: ENSG00000100987, VSX1, visual system homeobox 1, [RH, Score=197, Expect=4e-60]; ENSG00000119614, VSX2, visual system homeobox 2, [RH, Score=196, Expect=2e-59]} {Mouse: ENSMUSG00000021239, Vsx2, visual system homeobox 2, [RH, Score=196, Expect=6e-60]; ENSMUSG00000033080, Vsx1, visual system homeobox 1, [RH, Score=195, Expect=2e-59]} {Dmel: FBgn0263512, Vsx2, Visual system homeobox 2, [RH, Score=204, Expect=3e-60]} {Celegans: WBGene00000435, ceh-10, Homeobox protein ceh-10, [RH, Score=204, Expect=2e-63]} {Smed: dd_Smed_v6_19286_0_1, dd_Smed_v6_19286_0_1, [RH, Score=211, Expect=2e-66]} {RNA1310_76393} {RNA815_51313} |
18. | MligTC455_50931 | 28 | 0.58 | Mlig455_046985, Mlig455_047028 | Neo: - Age: - |
FCN2 | 1.939 | - | - | - | - | 0.939 | 1.000 | Mlig455_046985 {REF} {Length: 3620} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=126.1]; PAN domain [PF14295.8, score=27.4]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=22.7]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=2e-15]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=2e-12]} {Dmel: FBgn0031804, CG9500, [Score=79.0, Expect=1e-15]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=59.7, Expect=6e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} Mlig455_047028 {REF} {Length: 1979} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=71.8]} {Human: ENSG00000160339, FCN2, ficolin 2, [Score=80.1, Expect=5e-16]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=70.5, Expect=8e-13]} {Dmel: FBgn0031804, CG9500, [Score=79.3, Expect=3e-16]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=60.5, Expect=1e-09]} {RNA1509_53291} {RNA1310_21728} {RNA815_9881} |
19. | MligTC455_14293 | 27 | 0.55 | Mlig455_005699 | Neo: - Age: - |
1.938 | - | - | - | - | 0.938 | 1.000 | Mlig455_005699 {REF} {Length: 220} {NoTransDecoderORF} {RNA1509_35414} {RNA1310_4580} | |
20. | MligTC455_12180 | 107 | 2.23 | Mlig455_038554, Mlig455_052202, Mlig455_053449 | Neo: - Age: logFC(26M/2M)=-0.655 Region-enriched R2: 5.717/0.01573 |
CNGA3 | 1.937 | - | - | - | - | 0.942 | 0.995 | Mlig455_038554 {REF} {Length: 2866} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=75.9]; Cyclic nucleotide-binding domain [PF00027.31, score=69.1]; Ion transport protein [PF00520.33, score=68.6]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [RH, Score=650, Expect=0.0]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [RH, Score=644, Expect=0.0]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [RH, Score=607, Expect=0.0]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [RH, Score=563, Expect=0.0]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [RH, Score=669, Expect=0.0]} {RNA1310_22950} {RNA815_16119} Mlig455_052202 {REF} {Length: 3203} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=76.1]; Cyclic nucleotide-binding domain [PF00027.31, score=69.1]; Ion transport protein [PF00520.33, score=68.2]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [RH, Score=650, Expect=0.0]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [RH, Score=644, Expect=0.0]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [RH, Score=605, Expect=0.0]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [RH, Score=563, Expect=0.0]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [RH, Score=667, Expect=0.0]} {RNA1310_22950} {RNA815_16119} Mlig455_053449 {REF} {Length: 991} {Pfam: C-terminal leucine zipper domain of cyclic nucleotide-gated channels [PF16526.7, score=79.9]; Cyclic nucleotide-binding domain [PF00027.31, score=29.1]} {Human: ENSG00000144191, CNGA3, cyclic nucleotide gated channel alpha 3, [Score=171, Expect=7e-50]} {Mouse: ENSMUSG00000026114, Cnga3, cyclic nucleotide gated channel alpha 3, [Score=161, Expect=2e-46]; ENSMUSG00000067220, Cnga1, cyclic nucleotide gated channel alpha 1, [Score=155, Expect=4e-44]} {Dmel: FBgn0261612, CngA, Cyclic nucleotide-gated ion channel subunit A, [Score=148, Expect=1e-41]} {Celegans: WBGene00006526, tax-4, Cyclic nucleotide-gated cation channel, [Score=149, Expect=3e-42]} {Smed: dd_Smed_v6_22398_0_1, dd_Smed_v6_22398_0_1, [Score=155, Expect=8e-45]} {RNA1310_61700} {RNA815_16119} |
21. | MligTC455_18185 | 11 | 0.23 | Mlig455_044004 | Neo: - Age: - |
STK32B | 1.932 | - | - | - | - | 0.932 | 1.000 | Mlig455_044004 {REF} {Length: 1959} {Pfam: Protein kinase domain [PF00069.27, score=179.2]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=89.1]; Kinase-like [PF14531.8, score=35.6]; Phosphotransferase enzyme family [PF01636.25, score=18.5]} {Human: ENSG00000152953, STK32B, serine/threonine kinase 32B, [RH, Score=394, Expect=5e-135]; ENSG00000169302, STK32A, serine/threonine kinase 32A, [RH, Score=382, Expect=2e-130]} {Mouse: ENSMUSG00000039954, Stk32a, serine/threonine kinase 32A, [RH, Score=402, Expect=2e-138]} {Dmel: FBgn0052944, CG32944, [Score=348, Expect=4e-117]} {Celegans: WBGene00010838, M03C11.1, [Score=315, Expect=3e-105]} {Smed: dd_Smed_v6_6683_0_1, dd_Smed_v6_6683_0_1, [RH, Score=385, Expect=2e-132]} {RNA1310_81424} {RNA815_49585} |
22. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
1.931 | - | - | - | - | 0.939 | 0.992 | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
23. | MligTC455_31273 | 40 | 0.83 | Mlig455_017570 | Neo: - Age: - |
JMJD6 | 1.931 | - | - | - | - | 0.944 | 0.987 | Mlig455_017570 {REF} {Length: 2550} {Pfam: Cupin-like domain [PF13621.8, score=84.8]; JmjC domain, hydroxylase [PF02373.24, score=41.9]; Cupin superfamily protein [PF08007.14, score=22.1]} {Human: ENSG00000070495, JMJD6, jumonji domain containing 6, arginine demethylase and lysine hydroxylase, [Score=81.6, Expect=3e-16]} {Mouse: ENSMUSG00000056962, Jmjd6, jumonji domain containing 6, [Score=79.0, Expect=2e-15]} {Dmel: FBgn0038948, PSR, phosphatidylserine receptor, [Score=77.8, Expect=3e-15]} {Celegans: WBGene00004205, psr-1, Bifunctional arginine demethylase and lysyl-hydroxylase psr-1, [Score=88.6, Expect=6e-19]} {Smed: dd_Smed_v6_12267_0_1, dd_Smed_v6_12267_0_1, [RH, Score=327, Expect=7e-108]} {RNA1310_17984} {RNA815_15470} |
24. | MligTC455_19585 | 83 | 1.72 | Mlig455_041765 | Neo: - |
PCDH11X | 1.93 | - | - | - | - | 0.976 | 0.954 | Mlig455_041765 {REF} {Length: 5069} {Pfam: Cadherin domain [PF00028.19, score=307.9]; Cadherin-like [PF08266.14, score=46.0]; Cadherin-like [PF16184.7, score=24.6]} {Human: ENSG00000102290, PCDH11X, protocadherin 11 X-linked, [Score=294, Expect=4e-84]; ENSG00000184226, PCDH9, protocadherin 9, [Score=293, Expect=4e-84]; ENSG00000099715, PCDH11Y, protocadherin 11 Y-linked, [Score=290, Expect=9e-83]} {Mouse: ENSMUSG00000034755, Pcdh11x, protocadherin 11 X-linked, [RH, Score=301, Expect=7e-86]} {Dmel: FBgn0001075, ft, fat, [Score=242, Expect=9e-66]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=206, Expect=4e-54]} {Smed: dd_Smed_v6_15181_0_1, dd_Smed_v6_15181_0_1, [RH, Score=275, Expect=2e-78]} {RNA1509_46943} {RNA1310_9721, RNA1509_46943} {RNA1509_46943, RNA815_23754} |
25. | MligTC455_07976 | 9 | 0.19 | Mlig455_026945 | Neo: - Age: - |
1.926 | - | - | - | - | 0.926 | 1.000 | Mlig455_026945 {REF} {Length: 1312} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=68.6]} {RNA1310_34740} {RNA815_15663} | |
26. | MligTC455_11306 | 10 | 0.2 | Mlig455_030223 | Neo: - Age: - |
ANGPT4 | 1.926 | - | - | - | - | 0.926 | 1.000 | Mlig455_030223 {REF} {Length: 1102} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=82.4]} {Human: ENSG00000101280, ANGPT4, angiopoietin 4, [Score=75.5, Expect=4e-15]; ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=72.8, Expect=2e-14]} {Mouse: ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=71.6, Expect=6e-14]; ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=70.5, Expect=1e-13]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=68.9, Expect=6e-13]; ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=68.6, Expect=6e-13]; ENSMUSG00000038742, Angptl6, angiopoietin-like 6, [Score=68.6, Expect=7e-13]} {Dmel: FBgn0087011, CG41520, [Score=60.8, Expect=2e-10]} {Celegans: WBGene00017013, ensh-1, [Score=46.6, Expect=7e-06]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=61.6, Expect=6e-11]} {RNA1509_28467} {RNA1310_29813.1} {RNA815_57322} |
27. | MligTC455_14795 | 8 | 0.16 | Mlig455_001604 | Neo: - Age: - |
NPR1 | 1.926 | - | - | - | - | 0.926 | 1.000 | Mlig455_001604 {REF} {Length: 2245} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=181.5]} {Human: ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=251, Expect=3e-71]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=243, Expect=2e-68]} {Mouse: ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=248, Expect=2e-70]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=244, Expect=1e-71]} {Dmel: FBgn0010197, Gyc32E, Guanyl cyclase at 32E, [Score=227, Expect=4e-63]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=224, Expect=2e-62]} {Smed: dd_Smed_v6_7644_0_1, dd_Smed_v6_7644_0_1, [Score=225, Expect=1e-62]} {RNA1310_77875} |
28. | MligTC455_14898 | 41 | 0.86 | Mlig455_011988 | Neo: - Age: - |
1.926 | - | - | - | - | 0.926 | 1.000 | Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
29. | MligTC455_43979 | 188 | 3.92 | Mlig455_000082, Mlig455_063749 | Neo: - Age: - |
GHSR | 1.926 | - | - | - | - | 0.926 | 1.000 | Mlig455_000082 {REF} {Length: 1342} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=53.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=18.2]} {Human: ENSG00000121853, GHSR, growth hormone secretagogue receptor, [Score=52.0, Expect=7e-07]} {Mouse: ENSMUSG00000051136, Ghsr, growth hormone secretagogue receptor, [Score=50.4, Expect=2e-06]} {Celegans: WBGene00018798, gnrr-1, GoNadotropin-Releasing hormone Receptor (GnRHR) related, [Score=48.9, Expect=3e-06]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=160, Expect=9e-47]} {RNA1310_30553} Mlig455_063749 {REF} {Length: 1323} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=48.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.4]} {Smed: dd_Smed_v6_60346_0_1, dd_Smed_v6_60346_0_1, [RH, Score=157, Expect=1e-45]} {RNA1310_30553} |
30. | MligTC455_51559 | 43 | 0.89 | Mlig455_002923, Mlig455_002941 | Neo: - Age: - Region-enriched R2: 6.806/0.01463 |
1.926 | - | - | - | - | 0.926 | 1.000 | Mlig455_002923 {REF} {Length: 1008} {RNA1310_77227} {RNA815_43894} Mlig455_002941 {REF} {Length: 897} {RNA1310_88681} {RNA815_43894} |
|
31. | MligTC455_14873 | 15 | 0.31 | Mlig455_021074 | Neo: - Age: - |
1.924 | - | - | - | - | 0.926 | 0.998 | Mlig455_021074 {REF} {Length: 1075} {Pfam: WSC domain [PF01822.21, score=52.6]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=46.6, Expect=8e-06]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=50.8, Expect=2e-07]} {RNA1310_33352.1} {RNA815_14158.1} | |
32. | MligTC455_46451 | 229 | 4.76 | Mlig455_017183 | Neo: - Age: Down-Up-Down Region-specific R2: 5.510 Region-enriched R2: 5.394/0.00018 Regeneration-downregulated R2: -2.986 Regeneration-depleted R2: -2.986 |
1.924 | - | - | - | - | 0.930 | 0.994 | Mlig455_017183 {REF} {Length: 657} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.6]} {RNA1310_62963} {RNA815_31352} | |
33. | MligTC455_18269 | 27 | 0.56 | Mlig455_008658 | Neo: - Age: - |
1.923 | - | - | - | - | 0.923 | 1.000 | Mlig455_008658 {REF} {Length: 1290} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=19.1]} {RNA1509_25258} {RNA1310_4580, RNA1509_25258} {RNA1509_25258, RNA815_9496.1} | |
34. | MligTC455_13635 | 16 | 0.33 | Mlig455_014568 | Neo: - Age: - |
1.922 | - | - | - | - | 0.935 | 0.987 | Mlig455_014568 {REF} {Length: 1825} | |
35. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
1.922 | - | - | - | - | 0.944 | 0.978 | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
36. | MligTC455_18945 | 41 | 0.86 | Mlig455_031602 | Neo: - Age: - |
1.92 | - | - | - | - | 0.920 | 1.000 | Mlig455_031602 {REF} {Length: 914} {RNA1310_75361} {RNA815_24378} | |
37. | MligTC455_43782 | 48 | 1 | Mlig455_044623, Mlig455_044681 | Neo: - Age: Up-Down-Up |
1.919 | - | - | - | - | 0.966 | 0.953 | Mlig455_044623 {REF} {Length: 2203} {RNA1310_60578} {RNA815_63573} Mlig455_044681 {REF} {Length: 2217} {Pfam: Glycine rich protein [PF12810.9, score=37.4]} {RNA1310_60578} {RNA815_63573} |
|
38. | MligTC455_03382 | 210 | 4.37 | Mlig455_057035 | Neo: - Age: - Region-enriched R2: 3.628/0.00113 |
PDE1C | 1.916 | - | - | - | - | 0.960 | 0.956 | Mlig455_057035 {REF} {Length: 2458} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=275.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=94.2]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [RH, Score=546, Expect=0.0]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [RH, Score=546, Expect=0.0]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [RH, Score=538, Expect=0.0]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [RH, Score=482, Expect=2e-164]} {Smed: dd_Smed_v6_11039_0_2, dd_Smed_v6_11039_0_2, [RH, Score=613, Expect=0.0]} {RNA1509_46084} {RNA1310_8143.1} {RNA815_6002} |
39. | MligTC455_10383 | 13 | 0.27 | Mlig455_040199 | Neo: - Age: - |
1.916 | - | - | - | - | 0.918 | 0.998 | Mlig455_040199 {REF} {Length: 860} {Pfam: Lectin C-type domain [PF00059.23, score=27.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
40. | MligTC455_13903 | 648 | 13.5 | Mlig455_013116 | Neo: - Age: logFC(26M/2M)=-1.026 Region-specific R2: 6.980 Region-enriched R2: 7.338/0.00000 |
1.916 | - | - | - | - | 0.918 | 0.998 | Mlig455_013116 {REF} {Length: 914} {RNA1509_28527} {RNA1310_38436.2, RNA1509_28527} {RNA1509_28527, RNA815_28856} | |
41. | MligTC455_26322 | 65 | 1.35 | Mlig455_042546 | Neo: - Age: - |
GRID2 | 1.916 | - | - | - | - | 0.929 | 0.987 | Mlig455_042546 {REF} {Length: 3217} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=49.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=35.5]; Receptor family ligand binding region [PF01094.30, score=33.7]} {Human: ENSG00000152208, GRID2, glutamate ionotropic receptor delta type subunit 2, [Score=127, Expect=3e-29]} {Mouse: ENSMUSG00000071424, Grid2, glutamate receptor, ionotropic, delta 2, [Score=129, Expect=5e-30]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=133, Expect=1e-31]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=105, Expect=6e-23]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=238, Expect=8e-71]} {RNA1310_27694} {RNA815_34664} |
42. | MligTC455_41382 | 65 | 1.35 | Mlig455_022554 | Neo: - Age: - Region-enriched R2: 5.596/0.01432 |
1.916 | - | - | - | - | 0.916 | 1.000 | Mlig455_022554 {REF} {Length: 503} {Pfam: Pancreatic hormone peptide [PF00159.20, score=18.9]} {RNA1310_81495} {RNA815_42745} | |
43. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
1.916 | - | - | - | - | 0.916 | 1.000 | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
44. | MligTC455_10966 | 15 | 0.31 | Mlig455_013154 | Neo: - Age: - |
1.914 | - | - | - | - | 0.926 | 0.988 | Mlig455_013154 {REF} {Length: 827} {Pfam: Lectin C-type domain [PF00059.23, score=21.8]} {RNA1509_20946} {RNA1310_65161} {RNA815_4785.1} | |
45. | MligTC455_12511 | 68 | 1.42 | Mlig455_017662 | Neo: - Age: - |
1.914 | - | - | - | - | 0.924 | 0.990 | Mlig455_017662 {REF} {Length: 906} {RNA1310_37507} {RNA815_32171} | |
46. | MligTC455_19552 | 288 | 6 | Mlig455_055936, Mlig455_068188 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.424 Region-specific R2: 6.302 Region-enriched R2: 4.919/0.00633 Regeneration-depleted R4: -5.607 |
1.913 | - | - | - | - | 0.926 | 0.987 | Mlig455_055936 {REF} {Length: 665} {RNA1310_71052} {RNA815_36745} Mlig455_068188 {REF} {Length: 714} {RNA1310_71052} {RNA815_36745} |
|
47. | MligTC455_50123 | 29 | 0.61 | Mlig455_063710 | Neo: - Age: - Region-enriched R4: 5.673/0.02044 |
1.913 | - | - | - | - | 0.926 | 0.987 | Mlig455_063710 {REF} {Length: 1119} | |
48. | MligTC455_51334 | 326 | 6.78 | Mlig455_011442, Mlig455_061180 | Neo: - |
1.913 | - | - | - | - | 0.914 | 0.999 | Mlig455_011442 {REF} {Length: 742} {RNA1310_57576.1} {RNA815_29867} Mlig455_061180 {REF} {Length: 769} {RNA1310_57576.1} {RNA815_29867} |
|
49. | MligTC455_12991 | 30 | 0.62 | Mlig455_037487 | Neo: - Age: - |
CHRNA6 | 1.912 | - | - | - | - | 0.912 | 1.000 | Mlig455_037487 {REF} {Length: 1592} {Pfam: Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=70.8]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=55.6]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=119, Expect=5e-29]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=110, Expect=4e-26]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=109, Expect=3e-25]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=107, Expect=5e-25]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=107, Expect=8e-25]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=106, Expect=2e-24]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=111, Expect=4e-26]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=111, Expect=1e-26]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=112, Expect=5e-27]} {RNA1310_100091} {RNA815_18433} |
50. | MligTC455_44966 | 574 | 11.95 | Mlig455_036578, Mlig455_057773 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.756 Region-specific R2: 7.016 Region-enriched R2: 7.690/0.00000 |
1.911 | - | - | - | - | 0.912 | 0.999 | Mlig455_036578 {REF} {Length: 1101} {RNA1509_34765} {RNA1310_57079} {RNA815_29388} Mlig455_057773 {REF} {Length: 629} {RNA1509_34765} {RNA1310_57079, RNA1509_34765} {RNA1509_34765, RNA815_29388} |
|
51. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
1.911 | - | - | - | - | 0.911 | 1.000 | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
52. | MligTC455_12512 | 80 | 1.68 | Mlig455_017689 | Neo: - Age: - |
1.91 | - | - | - | - | 0.913 | 0.997 | Mlig455_017689 {REF} {Length: 934} {RNA1310_37507} {RNA815_32171} | |
53. | MligTC455_51807 | 28 | 0.59 | Mlig455_046394 | Neo: - Age: - |
GPSM2 | 1.91 | - | - | - | - | 0.920 | 0.990 | Mlig455_046394 {REF} {Length: 3388} {Pfam: Tetratricopeptide repeat [PF13424.8, score=114.4]; Tetratricopeptide repeat [PF13176.8, score=96.0]; Tetratricopeptide repeat [PF00515.30, score=94.3]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=55.0]; Tetratricopeptide repeat [PF13181.8, score=42.2]; Tetratricopeptide repeat [PF13374.8, score=32.8]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.1]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=542, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=532, Expect=1e-180]; ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=511, Expect=1e-172]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=530, Expect=2e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=7e-80]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=477, Expect=1e-159]} {RNA1310_18538} {RNA815_41322} |
54. | MligTC455_54633 | 10 | 0.22 | Mlig455_016883 | Neo: - Age: - |
1.91 | - | - | - | - | 0.923 | 0.987 | Mlig455_016883 {REF} {Length: 283} {NoTransDecoderORF} | |
55. | MligTC455_50694 | 602 | 12.54 | Mlig455_058794, Mlig455_070066 | Neo: - Age: Down-Down-Up Region-specific R2: 5.478 Region-enriched R2: 3.805/0.01454 |
1.909 | - | - | - | - | 0.914 | 0.995 | Mlig455_058794 {REF} {Length: 776} {RNA1310_76208} {RNA815_49041} Mlig455_070066 {REF} {Length: 781} {RNA1310_76208} {RNA815_49041} |
|
56. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
1.908 | - | - | - | - | 0.928 | 0.980 | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
57. | MligTC455_50455 | 972 | 20.25 | Mlig455_070346 | Neo: - Age: - Region-specific R2: 4.855 Region-enriched R2: 5.186/0.00000 |
1.908 | - | - | - | - | 0.910 | 0.998 | Mlig455_070346 {REF} {Length: 932} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=34.4]; Nematode insulin-related peptide beta type [PF03488.16, score=21.4]} {RNA1509_18514, RNA1509_58074} {RNA1310_51990, RNA1509_18514, RNA1509_58074} {RNA1509_18514, RNA1509_58074, RNA815_25071} | |
58. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 1.907 | - | - | - | - | 0.910 | 0.997 | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
59. | MligTC455_40687 | 28 | 0.58 | Mlig455_040563, Mlig455_062078 | Neo: - Age: - |
PDE1C | 1.906 | - | - | - | - | 0.930 | 0.976 | Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402} Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704} |
60. | MligTC455_19775 | 36 | 0.74 | Mlig455_060359 | Neo: - Age: - |
FCN1 | 1.906 | - | - | - | - | 0.952 | 0.954 | Mlig455_060359 {REF} {Length: 1109} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.9]} {Human: ENSG00000085265, FCN1, ficolin 1, [Score=99.0, Expect=2e-23]; ENSG00000142748, FCN3, ficolin 3, [Score=99.0, Expect=1e-23]; ENSG00000160339, FCN2, ficolin 2, [Score=98.2, Expect=2e-23]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [Score=100, Expect=3e-24]} {Dmel: FBgn0034160, CG5550, [Score=97.8, Expect=7e-24]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=90.1, Expect=4e-20]} {RNA1310_67383} {RNA815_45536} |
61. | MligTC455_18100 | 17 | 0.36 | Mlig455_069127 | Neo: - Age: - |
PPA1 | 1.905 | - | - | - | - | 0.917 | 0.988 | Mlig455_069127 {REF} {Length: 2015} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1509_39915} {RNA1310_57333.1} {RNA815_22340} |
62. | MligTC455_43715 | 48 | 0.99 | Mlig455_034191 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.969/0.00817 |
1.905 | - | - | - | - | 0.905 | 1.000 | Mlig455_034191 {REF} {Length: 895} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250} | |
63. | MligTC455_14085 | 29 | 0.61 | Mlig455_002893 | Neo: - Age: Up-Down-Down Region-enriched R2: 6.406/0.01193 |
PPP2R5D | 1.904 | - | - | - | - | 0.904 | 1.000 | Mlig455_002893 {REF} {Length: 4141} {Pfam: Protein phosphatase 2A regulatory B subunit (B56 family) [PF01603.22, score=580.3]} {Human: ENSG00000112640, PPP2R5D, protein phosphatase 2 regulatory subunit B'delta, [RH, Score=675, Expect=0.0]; ENSG00000078304, PPP2R5C, protein phosphatase 2 regulatory subunit B'gamma, [RH, Score=647, Expect=0.0]} {Mouse: ENSMUSG00000059409, Ppp2r5d, protein phosphatase 2, regulatory subunit B', delta, [RH, Score=677, Expect=0.0]; ENSMUSG00000017843, Ppp2r5c, protein phosphatase 2, regulatory subunit B', gamma, [RH, Score=645, Expect=0.0]} {Dmel: FBgn0042693, wrd, well-rounded, [RH, Score=654, Expect=0.0]} {Celegans: WBGene00007554, pptr-2, Protein Phosphatase 2A (Two A) Regulatory subunit, [RH, Score=638, Expect=0.0]} {Smed: dd_Smed_v6_3379_0_1, dd_Smed_v6_3379_0_1, [RH, Score=665, Expect=0.0]} {RNA1509_7339} {RNA1310_39381} {RNA815_26062} |
64. | MligTC455_49285 | 164 | 3.41 | Mlig455_004486, Mlig455_037380 | Neo: - Age: - Region-specific R2: 6.095 Region-enriched R2: 5.942/0.00244 |
LEF1 | 1.904 | - | - | - | - | 0.917 | 0.987 | Mlig455_004486 {REF} {Length: 3612} {Pfam: HMG (high mobility group) box [PF00505.21, score=30.1]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [Score=105, Expect=2e-24]; ENSG00000081059, TCF7, transcription factor 7, [Score=103, Expect=3e-25]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [Score=100, Expect=2e-22]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [Score=105, Expect=6e-25]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [Score=101, Expect=8e-24]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [Score=100, Expect=1e-22]} {Dmel: FBgn0085432, pan, pangolin, [Score=103, Expect=1e-23]} {Celegans: WBGene00004077, pop-1, [Score=82.0, Expect=8e-17]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [Score=114, Expect=3e-29]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141} Mlig455_037380 {REF} {Length: 3365} {Pfam: HMG (high mobility group) box [PF00505.21, score=78.7]; HMG-box domain [PF09011.12, score=32.5]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=156, Expect=1e-43]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=154, Expect=7e-41]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=154, Expect=3e-44]; ENSG00000148737, TCF7L2, transcription factor 7 like 2, [RH, Score=150, Expect=6e-44]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=157, Expect=9e-44]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=156, Expect=1e-41]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=153, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=155, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=104, Expect=4e-24]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=165, Expect=2e-48]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141} |
65. | MligTC455_53233 | 1483 | 30.9 | Mlig455_037746, Mlig455_069921 | Neo: - Age: - Region-specific R2: 7.323 Region-enriched R2: 7.524/0.00000 Regeneration-downregulated R2: -3.635 Regeneration-depleted R2: -3.635 |
PKD2 | 1.904 | - | - | - | - | 0.912 | 0.992 | Mlig455_037746 {REF} {Length: 3024} {Pfam: Polycystin cation channel [PF08016.14, score=468.5]; Ion transport protein [PF00520.33, score=85.9]; EF-hand domain pair [PF13499.8, score=21.3]; EF hand [PF00036.34, score=21.2]; EF-hand domain [PF13405.8, score=18.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=708, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=306, Expect=2e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=379, Expect=1e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=719, Expect=0.0]} {RNA1509_30624, RNA1509_6992} {RNA1310_6033, RNA1509_30624} {RNA1509_30624, RNA815_1577.1} Mlig455_069921 {REF} {Length: 3030} {Pfam: Polycystin cation channel [PF08016.14, score=467.0]; Ion transport protein [PF00520.33, score=85.5]; EF hand [PF00036.34, score=21.3]; EF-hand domain pair [PF13499.8, score=21.3]; EF-hand domain [PF13405.8, score=18.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=707, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=304, Expect=8e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=377, Expect=3e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=716, Expect=0.0]} {RNA1509_6992} {RNA1310_6033, RNA1509_6992} {RNA1509_6992, RNA815_1577.1} |
66. | MligTC455_12446 | 8 | 0.17 | Mlig455_018624, Mlig455_018810 | Neo: - Age: - |
CHRNA10, CHRNA7 | 1.903 | - | - | - | - | 0.914 | 0.989 | Mlig455_018624 {REF} {Length: 3606} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.6]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=112.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=72.0]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=143, Expect=2e-35]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=142, Expect=2e-35]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=140, Expect=1e-34]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=140, Expect=1e-34]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=136, Expect=2e-33]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=145, Expect=2e-36]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=141, Expect=3e-35]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=140, Expect=2e-35]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=139, Expect=2e-34]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=142, Expect=2e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=3e-36]} {Smed: dd_Smed_v6_18184_0_1, dd_Smed_v6_18184_0_1, [Score=138, Expect=2e-34]} {RNA1509_9118} {RNA1310_65904} {RNA815_40596} Mlig455_018810 {REF} {Length: 2717} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=120.6]; Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=112.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=72.2]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=141, Expect=2e-35]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=140, Expect=2e-34]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=139, Expect=2e-34]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=139, Expect=2e-34]; ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=138, Expect=4e-34]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=145, Expect=2e-36]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=141, Expect=2e-35]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=140, Expect=8e-35]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=140, Expect=7e-35]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=142, Expect=1e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=4e-36]} {Smed: dd_Smed_v6_8058_0_1, dd_Smed_v6_8058_0_1, [Score=139, Expect=1e-34]} {RNA1509_9118} {RNA1310_84333} {RNA815_40596} |
67. | MligTC455_29412 | 46 | 0.96 | Mlig455_000627, Mlig455_008268, Mlig455_040614 | Neo: - Age: Up-Down-Up |
1.903 | - | - | - | - | 0.906 | 0.997 | Mlig455_000627 {REF} {Length: 1331} {RNA1310_62571} {RNA815_30942} Mlig455_008268 {REF} {Length: 1779} {RNA1509_47298} {RNA1310_98344} {RNA815_10804.1} Mlig455_040614 {REF} {Length: 1016} |
|
68. | MligTC455_33440 | 62 | 1.29 | Mlig455_053806, Mlig455_053807 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.142/0.02950 |
GRID1 | 1.903 | - | - | - | - | 0.921 | 0.982 | Mlig455_053806 {REF} {Length: 3070} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.7]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=39.8]; Receptor family ligand binding region [PF01094.30, score=28.6]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=145, Expect=2e-35]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=143, Expect=2e-34]} {Dmel: FBgn0038837, CG3822, [Score=126, Expect=2e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=257, Expect=1e-77]} {RNA1310_13880.2} {RNA815_12458} Mlig455_053807 {REF} {Length: 3142} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=38.3]; Receptor family ligand binding region [PF01094.30, score=36.5]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=139, Expect=2e-33]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=137, Expect=1e-32]} {Dmel: FBgn0038837, CG3822, [Score=125, Expect=5e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=117, Expect=1e-26]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=259, Expect=2e-78]} {RNA1310_13880.2} {RNA815_12458} |
69. | MligTC455_50778 | 36 | 0.76 | Mlig455_042296 | Neo: - Age: - |
GPR50 | 1.903 | - | - | - | - | 0.904 | 0.999 | Mlig455_042296 {REF} {Length: 1415} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=116.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=40.0]; Olfactory receptor [PF13853.8, score=34.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=33.9]} {Human: ENSG00000102195, GPR50, G protein-coupled receptor 50, [Score=124, Expect=4e-31]; ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=119, Expect=2e-30]} {Mouse: ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=120, Expect=4e-31]; ENSMUSG00000056380, Gpr50, G-protein-coupled receptor 50, [Score=119, Expect=2e-29]; ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=118, Expect=5e-30]} {Dmel: FBgn0038980, Octbeta1R, Octopamine beta1 receptor, [Score=92.0, Expect=1e-20]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=69.7, Expect=4e-13]} {Smed: dd_Smed_v6_65999_0_1, dd_Smed_v6_65999_0_1, [Score=84.7, Expect=1e-18]} {RNA1310_66047} {RNA815_34066} |
70. | MligTC455_13846 | 32 | 0.67 | Mlig455_013761 | Neo: - Age: - |
CALM2 | 1.901 | - | - | - | - | 0.926 | 0.975 | Mlig455_013761 {REF} {Length: 941} {Pfam: EF hand [PF00036.34, score=94.2]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13499.8, score=83.6]; EF hand [PF13202.8, score=77.1]; EF-hand domain pair [PF13833.8, score=42.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=31.3]; EF-hand domain [PF14658.8, score=23.8]; Ca2+ insensitive EF hand [PF08726.12, score=21.5]; Caleosin related protein [PF05042.15, score=21.3]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=60.1, Expect=1e-11]; ENSG00000160014, CALM3, calmodulin 3, [Score=60.1, Expect=1e-11]; ENSG00000198668, CALM1, calmodulin 1, [Score=60.1, Expect=1e-11]; ENSG00000178363, CALML3, calmodulin like 3, [Score=59.3, Expect=2e-11]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=60.5, Expect=1e-11]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=60.1, Expect=8e-12]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=60.1, Expect=8e-12]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=59.7, Expect=1e-11]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=60.8, Expect=3e-12]} {Celegans: WBGene00019352, K03A1.4, [Score=70.9, Expect=8e-16]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=97.4, Expect=1e-26]} {RNA1310_47452} {RNA815_31258} |
71. | MligTC455_50099 | 170 | 3.55 | Mlig455_030606, Mlig455_030681 | Neo: - Age: Up-Down-Down |
SLC4A11 | 1.901 | - | - | - | - | 0.915 | 0.986 | Mlig455_030606 {REF} {Length: 3525} {Pfam: HCO3- transporter family [PF00955.23, score=528.0]; Band 3 cytoplasmic domain [PF07565.15, score=23.9]; Phosphoenolpyruvate-dependent sugar phosphotransferase system, EIIA 2 [PF00359.24, score=22.2]} {Human: ENSG00000088836, SLC4A11, solute carrier family 4 member 11, [RH, Score=553, Expect=0.0]} {Mouse: ENSMUSG00000074796, Slc4a11, solute carrier family 4, sodium bicarbonate transporter-like, member 11, [RH, Score=540, Expect=2e-179]} {Dmel: FBgn0259111, Ndae1, Na[+]-driven anion exchanger 1, [Score=239, Expect=4e-66]} {Celegans: WBGene00019018, abts-3, Anion transporter ABTS-3; Anion/Bicarbonate TranSporter family, [RH, Score=685, Expect=0.0]} {Smed: dd_Smed_v6_16577_0_1, dd_Smed_v6_16577_0_1, [RH, Score=899, Expect=0.0]} {RNA1509_55902} {RNA1310_18543} {RNA815_14015} Mlig455_030681 {REF} {Length: 2174} {Pfam: HCO3- transporter family [PF00955.23, score=526.7]; Band 3 cytoplasmic domain [PF07565.15, score=23.8]; Phosphoenolpyruvate-dependent sugar phosphotransferase system, EIIA 2 [PF00359.24, score=22.0]} {Human: ENSG00000088836, SLC4A11, solute carrier family 4 member 11, [RH, Score=547, Expect=3e-180]} {Mouse: ENSMUSG00000074796, Slc4a11, solute carrier family 4, sodium bicarbonate transporter-like, member 11, [RH, Score=533, Expect=2e-175]} {Dmel: FBgn0259111, Ndae1, Na[+]-driven anion exchanger 1, [Score=242, Expect=3e-66]} {Celegans: WBGene00019018, abts-3, Anion transporter ABTS-3; Anion/Bicarbonate TranSporter family, [RH, Score=680, Expect=0.0]} {Smed: dd_Smed_v6_16577_0_1, dd_Smed_v6_16577_0_1, [RH, Score=904, Expect=0.0]} {RNA1509_55902} {RNA1310_18543} {RNA815_14015} |
72. | MligTC455_50777 | 40 | 0.83 | Mlig455_042072 | Neo: - Age: - |
MTNR1B | 1.901 | - | - | - | - | 0.908 | 0.993 | Mlig455_042072 {REF} {Length: 2881} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.0]; Olfactory receptor [PF13853.8, score=24.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.0]} {Human: ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=94.4, Expect=2e-21]; ENSG00000168412, MTNR1A, melatonin receptor 1A, [Score=90.1, Expect=5e-20]} {Mouse: ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=94.0, Expect=2e-21]; ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=89.4, Expect=6e-20]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=57.0, Expect=7e-09]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=52.0, Expect=2e-07]} {Smed: dd_Smed_v6_19535_0_1, dd_Smed_v6_19535_0_1, [Score=95.5, Expect=2e-22]} {RNA1310_66047} {RNA815_34066} |
73. | MligTC455_45487 | 110 | 2.3 | Mlig455_004129, Mlig455_060457 | Neo: - Age: - |
1.9 | - | - | - | - | 0.901 | 0.999 | Mlig455_004129 {REF} {Length: 1131} {Pfam: PAN domain [PF00024.28, score=18.8]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=64.3, Expect=2e-12]} {RNA1310_37660} {RNA815_17816.1} Mlig455_060457 {REF} {Length: 1507} {Pfam: PAN domain [PF00024.28, score=19.5]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=64.3, Expect=2e-12]} {RNA1509_54623} {RNA1310_33480} {RNA815_17816.1} |
|
74. | MligTC455_26356 | 62 | 1.3 | Mlig455_042551 | Neo: - |
GRIK2 | 1.899 | - | - | - | - | 0.899 | 1.000 | Mlig455_042551 {REF} {Length: 2917} {Pfam: Ligand-gated ion channel [PF00060.28, score=82.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=60.7]; Receptor family ligand binding region [PF01094.30, score=32.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=27.3]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=144, Expect=9e-35]; ENSG00000152208, GRID2, glutamate ionotropic receptor delta type subunit 2, [Score=141, Expect=7e-34]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=143, Expect=1e-34]; ENSMUSG00000071424, Grid2, glutamate receptor, ionotropic, delta 2, [Score=142, Expect=2e-34]} {Dmel: FBgn0051201, GluRIIE, Glutamate receptor IIE, [Score=119, Expect=3e-27]} {Celegans: WBGene00001616, glr-5, GLutamate Receptor family (AMPA), [Score=123, Expect=2e-28]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=247, Expect=4e-74]} {RNA1310_21865} {RNA815_26044} |
75. | MligTC455_38162 | 710 | 14.8 | Mlig455_045004 | Neo: - Age: Down-Up-Up Region-specific R2: 5.269 Region-enriched R2: 5.838/0.00000 Regeneration-downregulated R2: -4.412 Regeneration-depleted R2: -4.412 |
1.899 | - | - | - | - | 0.902 | 0.997 | Mlig455_045004 {REF} {Length: 659} {Smed: dd_Smed_v6_4046_0_1, dd_Smed_v6_4046_0_1, [Score=57.8, Expect=2e-12]} {RNA1509_50998, RNA1509_57106} {RNA1310_56015, RNA1509_50998, RNA1509_57106} {RNA1509_50998, RNA1509_57106, RNA815_29915} | |
76. | MligTC455_31104 | 22 | 0.46 | Mlig455_040032, Mlig455_070983 | Neo: - Age: - |
SYT17 | 1.896 | - | - | - | - | 0.926 | 0.970 | Mlig455_040032 {REF} {Length: 2712} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} Mlig455_070983 {REF} {Length: 1947} {Pfam: C2 domain [PF00168.32, score=79.2]} {Human: ENSG00000103528, SYT17, synaptotagmin 17, [Score=127, Expect=1e-30]} {Mouse: ENSMUSG00000058420, Syt17, synaptotagmin XVII, [Score=126, Expect=1e-30]} {Dmel: FBgn0028400, Syt4, Synaptotagmin 4, [Score=88.6, Expect=2e-18]} {Celegans: WBGene00004922, snt-2, Synaptotagmin 2, [Score=94.0, Expect=1e-20]} {Smed: dd_Smed_v6_19213_0_1, dd_Smed_v6_19213_0_1, [Score=96.7, Expect=3e-21]} {RNA1310_17303} |
77. | MligTC455_43714 | 152 | 3.18 | Mlig455_000684, Mlig455_000736 | Neo: - Age: - |
1.896 | - | - | - | - | 0.896 | 1.000 | Mlig455_000684 {REF} {Length: 796} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} Mlig455_000736 {REF} {Length: 797} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} |
|
78. | MligTC455_30160 | 55 | 1.15 | Mlig455_035128 | Neo: - Age: - Region-enriched R2: 5.270/0.01686 |
TCF7L1 | 1.895 | - | - | - | - | 0.960 | 0.935 | Mlig455_035128 {REF} {Length: 2946} {Pfam: HMG (high mobility group) box [PF00505.21, score=79.2]; HMG-box domain [PF09011.12, score=34.5]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=1e-42]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=158, Expect=7e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=2e-41]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=8e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=158, Expect=9e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=156, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=6e-48]} {RNA1509_46571} {RNA1310_11181} {RNA815_36690} |
79. | MligTC455_18099 | 24 | 0.51 | Mlig455_036525 | Neo: - Age: - |
PPA1 | 1.894 | - | - | - | - | 0.901 | 0.993 | Mlig455_036525 {REF} {Length: 1911} {Pfam: Inorganic pyrophosphatase [PF00719.21, score=181.8]} {Human: ENSG00000180817, PPA1, pyrophosphatase (inorganic) 1, [Score=304, Expect=2e-103]; ENSG00000138777, PPA2, pyrophosphatase (inorganic) 2, [Score=295, Expect=4e-99]} {Mouse: ENSMUSG00000020089, Ppa1, pyrophosphatase (inorganic) 1, [Score=307, Expect=9e-105]} {Dmel: FBgn0016687, Nurf-38, Nucleosome remodeling factor - 38kD, [Score=303, Expect=2e-103]} {Celegans: WBGene00008149, pyp-1, Probable inorganic pyrophosphatase 1, [Score=315, Expect=5e-108]} {Smed: dd_Smed_v6_625_0_1, dd_Smed_v6_625_0_1, [Score=290, Expect=2e-98]} {RNA1310_57333.1} {RNA815_22340} |
80. | MligTC455_31901 | 18 | 0.38 | Mlig455_022355 | Neo: - Age: - |
1.894 | - | - | - | - | 0.894 | 1.000 | Mlig455_022355 {REF} {Length: 541} {Pfam: PAN domain [PF00024.28, score=19.0]} {RNA1310_125793} {RNA815_23776.1} | |
81. | MligTC455_46067 | 548 | 11.42 | Mlig455_054518, Mlig455_055436, Mlig455_055448 | Neo: - Age: Up-Down-Down Region-enriched R4: 4.305/0.04262 |
GRIK3, GRIK4 | 1.894 | - | - | - | - | 0.899 | 0.995 | Mlig455_054518 {REF} {Length: 4725} {Pfam: Ligand-gated ion channel [PF00060.28, score=109.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=91.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=81.2]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=222, Expect=5e-60]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=222, Expect=6e-60]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=218, Expect=3e-58]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=216, Expect=3e-58]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=215, Expect=1e-57]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=213, Expect=9e-57]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=213, Expect=9e-57]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=224, Expect=2e-60]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=224, Expect=9e-61]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=220, Expect=2e-59]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=216, Expect=2e-58]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=215, Expect=1e-57]} {Dmel: FBgn0031634, Ir25a, Ionotropic receptor 25a, [RH, Score=296, Expect=6e-86]} {Celegans: WBGene00001618, glr-7, GLutamate Receptor family (AMPA), [RH, Score=312, Expect=2e-94]} {Smed: dd_Smed_v6_16476_0_1, dd_Smed_v6_16476_0_1, [RH, Score=674, Expect=0.0]} {RNA1509_14215, RNA1509_40992} {RNA1310_5620.1, RNA1509_14215, RNA1509_40992} {RNA1509_14215, RNA1509_40992, RNA815_1965} Mlig455_055436 {REF} {Length: 4732} {Pfam: Ligand-gated ion channel [PF00060.28, score=109.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=90.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=81.1]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=219, Expect=6e-59]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=218, Expect=7e-59]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=218, Expect=7e-59]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=216, Expect=3e-58]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=216, Expect=9e-58]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=211, Expect=2e-56]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=209, Expect=1e-55]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=226, Expect=3e-61]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=221, Expect=1e-59]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=216, Expect=2e-58]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=216, Expect=2e-58]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=216, Expect=3e-58]} {Dmel: FBgn0031634, Ir25a, Ionotropic receptor 25a, [RH, Score=297, Expect=2e-86]} {Celegans: WBGene00001618, glr-7, GLutamate Receptor family (AMPA), [RH, Score=313, Expect=2e-94]} {Smed: dd_Smed_v6_16476_0_1, dd_Smed_v6_16476_0_1, [RH, Score=674, Expect=0.0]} {RNA1509_40992} {RNA1310_5620.1} {RNA815_1965} Mlig455_055448 {REF} {Length: 4726} {Pfam: Ligand-gated ion channel [PF00060.28, score=109.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=90.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=81.1]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=219, Expect=9e-59]; ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=218, Expect=9e-59]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=218, Expect=8e-59]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=217, Expect=2e-58]; ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=216, Expect=7e-58]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=213, Expect=6e-57]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=209, Expect=1e-55]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=225, Expect=4e-61]; ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=221, Expect=1e-59]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=217, Expect=9e-59]; ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=216, Expect=5e-58]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=216, Expect=3e-58]} {Dmel: FBgn0031634, Ir25a, Ionotropic receptor 25a, [RH, Score=297, Expect=2e-86]} {Celegans: WBGene00001618, glr-7, GLutamate Receptor family (AMPA), [RH, Score=313, Expect=2e-94]} {Smed: dd_Smed_v6_16476_0_1, dd_Smed_v6_16476_0_1, [RH, Score=674, Expect=0.0]} {RNA1509_32892, RNA1509_40992} {RNA1310_5620.1, RNA1509_32892} {RNA1509_32892, RNA815_1965} |
82. | MligTC455_35945 | 130 | 2.71 | Mlig455_065474 | Neo: - Age: Up-Down-Up |
1.893 | - | - | - | - | 0.896 | 0.997 | Mlig455_065474 {REF} {Length: 1654} {RNA1310_22530} {RNA815_54411} | |
83. | MligTC455_49434 | 157 | 3.26 | Mlig455_068252, Mlig455_068272 | Neo: - Age: - |
1.893 | - | - | - | - | 0.936 | 0.957 | Mlig455_068252 {REF} {Length: 718} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.5, Expect=1e-12]} {RNA1310_75052} Mlig455_068272 {REF} {Length: 1055} {Smed: dd_Smed_v6_17523_0_1, dd_Smed_v6_17523_0_1, [Score=63.2, Expect=2e-12]} {RNA1310_75052} |
|
84. | MligTC455_11558 | 137 | 2.85 | Mlig455_058259 | Neo: - Age: logFC(26M/2M)=-0.792 |
1.892 | - | - | - | - | 0.929 | 0.963 | Mlig455_058259 {REF} {Length: 896} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=19.9]} {RNA1509_58923} {RNA1310_41706, RNA1509_58923} {RNA1509_58923, RNA815_20876} | |
85. | MligTC455_15949 | 37 | 0.76 | Mlig455_059880 | Neo: - Age: - |
1.891 | - | - | - | - | 0.915 | 0.976 | Mlig455_059880 {REF} {Length: 1226} {Pfam: Lectin C-type domain [PF00059.23, score=39.5]} {Dmel: FBgn0031373, CG15358, [Score=52.8, Expect=4e-08]} {RNA1310_120903} | |
86. | MligTC455_36194 | 30 | 0.61 | Mlig455_064360, Mlig455_064382 | Neo: - Age: - |
B3GNT4 | 1.891 | - | - | - | - | 0.914 | 0.977 | Mlig455_064360 {REF} {Length: 3119} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.0, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=3e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.2, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=91.7, Expect=1e-19]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} Mlig455_064382 {REF} {Length: 3084} {Pfam: Galactosyltransferase [PF01762.23, score=116.7]} {Human: ENSG00000176383, B3GNT4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=101, Expect=5e-23]} {Mouse: ENSMUSG00000031803, B3gnt3, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3, [Score=94.7, Expect=9e-21]; ENSMUSG00000051650, B3gnt2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2, [Score=94.4, Expect=2e-20]; ENSMUSG00000029431, B3gnt4, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000067370, B3galt4, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4, [Score=93.6, Expect=2e-20]; ENSMUSG00000022686, B3gnt5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=92.0, Expect=9e-20]} {Dmel: FBgn0031988, CG8668, [Score=90.1, Expect=8e-19]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [RH, Score=90.9, Expect=8e-20]} {Smed: dd_Smed_v6_9789_0_1, dd_Smed_v6_9789_0_1, [Score=165, Expect=5e-47]} {RNA1310_43172} {RNA815_26726} |
87. | MligTC455_19875 | 82 | 1.71 | Mlig455_024408 | Neo: - Age: Down-Up-Down |
1.89 | - | - | - | - | 0.951 | 0.939 | Mlig455_024408 {REF} {Length: 2479} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_4968.1} {RNA815_23744} | |
88. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 1.889 | - | - | - | - | 0.894 | 0.995 | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
89. | MligTC455_47675 | 2101 | 43.77 | Mlig455_061675, Mlig455_063136 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.812 Region-specific R2: 4.381 Region-enriched R2: 4.099/0.00000 |
CLEC18C | 1.889 | - | - | - | - | 0.890 | 0.999 | Mlig455_061675 {REF} {Length: 2392} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=60.3]} {Human: ENSG00000157335, CLEC18C, C-type lectin domain family 18 member C, [RH, Score=75.5, Expect=1e-13]; ENSG00000140839, CLEC18B, C-type lectin domain family 18 member B, [RH, Score=75.1, Expect=1e-13]} {Mouse: ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=77.8, Expect=1e-15]; ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=75.9, Expect=7e-15]} {Celegans: WBGene00003055, lon-1, LONg, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [Score=134, Expect=5e-33]} {RNA1509_48080} {RNA1310_16102.1} {RNA815_9265} Mlig455_063136 {REF} {Length: 2649} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=60.7]} {Human: ENSG00000157335, CLEC18C, C-type lectin domain family 18 member C, [RH, Score=77.8, Expect=1e-14]; ENSG00000140839, CLEC18B, C-type lectin domain family 18 member B, [RH, Score=77.4, Expect=1e-14]; ENSG00000157322, CLEC18A, C-type lectin domain family 18 member A, [RH, Score=77.0, Expect=2e-14]} {Mouse: ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=78.2, Expect=5e-16]; ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=76.3, Expect=3e-14]} {Celegans: WBGene00003055, lon-1, LONg, [Score=63.5, Expect=6e-11]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=136, Expect=3e-34]} {RNA1509_48080} {RNA1310_16102.1} {RNA815_9265} |
90. | MligTC455_17578 | 447 | 9.32 | Mlig455_010738 | Neo: - Age: Down-Up-Up Region-specific R2: 8.320 Region-enriched R2: 9.793/0.00000 |
1.888 | - | - | - | - | 0.892 | 0.996 | Mlig455_010738 {REF} {Length: 642} {RNA1509_48297, RNA1509_55742} {RNA1310_84623, RNA1509_48297, RNA1509_55742} {RNA1509_48297, RNA1509_55742, RNA815_45356} | |
91. | MligTC455_38903 | 37 | 0.76 | Mlig455_055963, Mlig455_056073 | Neo: - Age: - |
KCNK5 | 1.888 | - | - | - | - | 0.908 | 0.980 | Mlig455_055963 {REF} {Length: 986} {Pfam: Ion channel [PF07885.18, score=106.1]; Ion transport protein [PF00520.33, score=26.1]} {Human: ENSG00000164626, KCNK5, potassium two pore domain channel subfamily K member 5, [Score=137, Expect=2e-36]} {Mouse: ENSMUSG00000023243, Kcnk5, potassium channel, subfamily K, member 5, [Score=133, Expect=4e-35]; ENSMUSG00000033854, Kcnk10, potassium channel, subfamily K, member 10, [Score=127, Expect=9e-33]} {Dmel: FBgn0017561, Ork1, Open rectifier K[+] channel 1, [Score=108, Expect=6e-26]} {Celegans: WBGene00006318, sup-9, Two pore potassium channel protein sup-9, [Score=101, Expect=8e-25]} {Smed: dd_Smed_v6_6116_0_1, dd_Smed_v6_6116_0_1, [Score=110, Expect=2e-27]} Mlig455_056073 {REF} {Length: 1284} {Pfam: Ion channel [PF07885.18, score=106.2]; Ion transport protein [PF00520.33, score=26.1]} {Human: ENSG00000164626, KCNK5, potassium two pore domain channel subfamily K member 5, [Score=137, Expect=2e-36]} {Mouse: ENSMUSG00000023243, Kcnk5, potassium channel, subfamily K, member 5, [Score=132, Expect=6e-35]; ENSMUSG00000033854, Kcnk10, potassium channel, subfamily K, member 10, [Score=126, Expect=1e-32]} {Dmel: FBgn0017561, Ork1, Open rectifier K[+] channel 1, [Score=106, Expect=2e-25]} {Celegans: WBGene00006318, sup-9, Two pore potassium channel protein sup-9, [Score=101, Expect=9e-25]} {Smed: dd_Smed_v6_6116_0_1, dd_Smed_v6_6116_0_1, [Score=110, Expect=2e-27]} {RNA1310_133484} |
92. | MligTC455_25072 | 4443 | 92.56 | Mlig455_015899 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.175 Region-enriched R2: 4.389/0.00000 |
PI16 | 1.887 | - | - | - | - | 0.904 | 0.983 | Mlig455_015899 {REF} {Length: 2017} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=112, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=5e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.5, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=5e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_5027} {RNA1310_1356.1} {RNA815_4508} |
93. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
1.885 | - | - | - | - | 0.909 | 0.976 | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
94. | MligTC455_35933 | 19 | 0.4 | Mlig455_033271 | Neo: - Age: - |
1.885 | - | - | - | - | 0.888 | 0.997 | Mlig455_033271 {REF} {Length: 1256} {RNA1310_22041} {RNA815_26444} | |
95. | MligTC455_48490 | 40 | 0.84 | Mlig455_020090 | Neo: - Age: - |
1.885 | - | - | - | - | 0.918 | 0.967 | Mlig455_020090 {REF} {Length: 2619} {RNA1310_71062} {RNA815_63441} | |
96. | MligTC455_15329 | 22 | 0.47 | Mlig455_060498 | Neo: - Age: - |
1.884 | - | - | - | - | 0.890 | 0.994 | Mlig455_060498 {REF} {Length: 1186} {Pfam: PAN domain [PF00024.28, score=18.9]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=63.9, Expect=4e-12]} {RNA1310_37660} {RNA815_17816.1} | |
97. | MligTC455_20953 | 115 | 2.4 | Mlig455_002904 | Neo: - Age: - Region-enriched R2: 5.041/0.00953 |
1.884 | - | - | - | - | 0.898 | 0.986 | Mlig455_002904 {REF} {Length: 1514} {RNA1310_19276} {RNA815_20827} | |
98. | MligTC455_42256 | 163 | 3.39 | Mlig455_054046 | Neo: - Age: Down-Up-Up |
LDB2 | 1.884 | - | - | - | - | 0.915 | 0.969 | Mlig455_054046 {REF} {Length: 2089} {Pfam: LIM-domain binding protein [PF01803.18, score=164.3]; LIM interaction domain (LID) [PF17916.3, score=55.5]} {Human: ENSG00000169744, LDB2, LIM domain binding 2, [RH, Score=390, Expect=4e-132]} {Mouse: ENSMUSG00000039706, Ldb2, LIM domain binding 2, [RH, Score=388, Expect=3e-131]} {Dmel: FBgn0013764, Chi, Chip, [RH, Score=332, Expect=9e-107]} {Celegans: WBGene00002261, ldb-1, F58A3.1a; LIM Domain Binding protein, [RH, Score=155, Expect=2e-40]} {Smed: dd_Smed_v6_3678_0_1, dd_Smed_v6_3678_0_1, [Score=321, Expect=1e-102]} {RNA1310_27326} {RNA815_22302} |
99. | MligTC455_49824 | 466 | 9.71 | Mlig455_036536 | Neo: - Age: - Region-specific R2: 4.841 Region-enriched R2: 3.862/0.00010 |
1.884 | - | - | - | - | 0.899 | 0.985 | Mlig455_036536 {REF} {Length: 1139} {Pfam: Nucleoporin FG repeat region [PF13634.8, score=21.2]} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [RH, Score=49.3, Expect=7e-08]} {RNA1509_18714, RNA1509_59524} {RNA1310_41906, RNA1509_18714, RNA1509_59524} {RNA1509_18714, RNA1509_59524, RNA815_24488} | |
100. | MligTC455_41967 | 159 | 3.32 | Mlig455_017184 | Neo: Int S/G2/M Age: Down-Up-Up Region-enriched R2: 7.330/0.00001 |
1.881 | - | - | - | - | 0.909 | 0.972 | Mlig455_017184 {REF} {Length: 1106} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=22.0]} {RNA1509_40628} {RNA1310_50753, RNA1509_40628} {RNA1509_40628, RNA815_21607} |